NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
+87.13%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.49B
AUM Growth
+$574M
Cap. Flow
-$375M
Cap. Flow %
-15.07%
Top 10 Hldgs %
64.37%
Holding
51
New
1
Increased
2
Reduced
3
Closed
5

Top Buys

1
AKUS
Akouos, Inc. Common Stock
AKUS
$96.7M
2
TRVI icon
Trevi Therapeutics
TRVI
$9.87M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$7.36M

Top Sells

1
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$295M
2
MRSN icon
Mersana Therapeutics
MRSN
$93.7M
3
EPZM
Epizyme, Inc
EPZM
$67.9M
4
ARDX icon
Ardelyx
ARDX
$17.3M
5
SURF
Surface Oncology, Inc. Common Stock
SURF
$6.2M

Sector Composition

1 Healthcare 79.03%
2 Technology 16.28%
3 Consumer Discretionary 2.25%
4 Industrials 0.58%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GNCA
26
DELISTED
Genocea Biosciences, Inc.
GNCA
$16.6M 0.67%
7,225,676
– –
CSBR icon
27
Champions Oncology
CSBR
$94.7M
$16.4M 0.66%
1,713,720
– –
SBBP
28
DELISTED
Strongbridge Biopharma plc.
SBBP
$15.7M 0.63%
4,141,308
– –
BE icon
29
Bloom Energy
BE
$12.8B
$14.5M 0.58%
1,333,333
– –
XENE icon
30
Xenon Pharmaceuticals
XENE
$2.98B
$12.4M 0.5%
992,107
– –
MRKR icon
31
Marker Therapeutics
MRKR
$11.2M
$10.4M 0.42%
500,000
– –
LUMO
32
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$8.69M 0.35%
526,663
– –
SYBX icon
33
Synlogic
SYBX
$17M
$8.59M 0.35%
281,961
– –
DZSI
34
DELISTED
DZS Inc. Common Stock
DZSI
$8.54M 0.34%
956,255
– –
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$8.28M 0.33%
7,140,450
– –
SENS icon
36
Senseonics Holdings
SENS
$372M
$6.25M 0.25%
16,023,830
-13,737,853
-46% -$5.36M
RIGL icon
37
Rigel Pharmaceuticals
RIGL
$714M
$5.94M 0.24%
324,315
– –
PHXM
38
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$5.72M 0.23%
62,500
– –
TRVN
39
DELISTED
Trevena, Inc.
TRVN
$5.72M 0.23%
6,099
– –
VRNA
40
Verona Pharma
VRNA
$9.18B
$5.71M 0.23%
1,219,674
– –
LXRX icon
41
Lexicon Pharmaceuticals
LXRX
$389M
$4.75M 0.19%
2,382,286
– –
TPST icon
42
Tempest Therapeutics
TPST
$44.5M
$3.11M 0.13%
9,060
– –
RGLS
43
DELISTED
Regulus Therapeutics
RGLS
$1.4M 0.06%
205,246
– –
AKTX
44
Akari Therapeutics
AKTX
$23.8M
$986K 0.04%
22,608
– –
TCON
45
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$680K 0.03%
17,336
– –
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$342K 0.01%
37,094
– –
XFOR icon
47
X4 Pharmaceuticals
XFOR
$83.1M
– –
-11,111
Closed -$3.33M
SURF
48
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-3,315,149
Closed -$6.2M
EPZM
49
DELISTED
Epizyme, Inc
EPZM
– –
-4,377,518
Closed -$67.9M
RARX
50
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-6,138,797
Closed -$295M
1
2
3